Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,247 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: Kato N. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class.
Suzuki E, Kaneko S, Okusaka T, Ikeda M, Yamaguchi K, Sugimoto R, Aramaki T, Asagi A, Yasui K, Sano K, Hosokawa A, Kato N, Ishii H, Sato T, Furuse J. Suzuki E, et al. Among authors: Kato N. Jpn J Clin Oncol. 2018 Apr 1;48(4):317-321. doi: 10.1093/jjco/hyy010. Jpn J Clin Oncol. 2018. PMID: 29474553 Clinical Trial.
Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.
Ishikawa K, Chiba T, Ooka Y, Suzuki E, Ogasawara S, Maeda T, Yokoyama M, Inoue M, Wakamatsu T, Kusakabe Y, Saito T, Tawada A, Arai M, Kanda T, Maruyama H, Imazeki F, Kato N. Ishikawa K, et al. Among authors: Kato N. Oncotarget. 2018 Apr 20;9(30):21560-21568. doi: 10.18632/oncotarget.25108. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765560 Free PMC article.
After adjusting these factors using propensity score matching (1:3 matching), patients treated with TACE (n=32) and those treated with RFA (n=96) were further analyzed. ...
After adjusting these factors using propensity score matching (1:3 matching), patients treated with TACE (n=32) and those treated wit …
Epigenetic dysregulation in hepatocellular carcinoma: an up-to-date review.
Nakamura M, Chiba T, Kanayama K, Kanzaki H, Saito T, Kusakabe Y, Kato N. Nakamura M, et al. Among authors: Kato N. Hepatol Res. 2019 Jan;49(1):3-13. doi: 10.1111/hepr.13250. Epub 2018 Oct 19. Hepatol Res. 2019. PMID: 30238570 Review.
CD4+ T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoires.
Nakagawa R, Muroyama R, Saeki C, Oikawa T, Kaise Y, Koike K, Arai J, Nakano M, Matsubara Y, Takano K, Hirata Y, Saruta M, Zeniya M, Kato N. Nakagawa R, et al. Among authors: Kato N. Hepatol Res. 2019 Jun;49(6):653-662. doi: 10.1111/hepr.13318. Epub 2019 Feb 26. Hepatol Res. 2019. PMID: 30690835
N-Ras dynamics in CD4(+) T cells were assessed by qRT-PCR and GTP-N-Ras activation assay. The TCR α- (TRA) and β-chain (TRB) repertoires on CD4(+) T cells were analyzed by NGS and profiled using hierarchical analysis. ...CONCLUSIONS: N-Ras was upregulated in
N-Ras dynamics in CD4(+) T cells were assessed by qRT-PCR and GTP-N-Ras activation assay. The TCR α- (TRA) and β-chain (TRB) r
Renal Dysfunction is a Risk Factor of Death after Gastric Endoscopic Submucosal Dissection in Elderly Patients Aged ≥80 Years.
Okimoto K, Arai M, Ishigami H, Taida T, Saito K, Maruoka D, Matsumura T, Nakagawa T, Katsuno T, Kato N. Okimoto K, et al. Among authors: Kato N. Can J Gastroenterol Hepatol. 2019 Sep 9;2019:7145182. doi: 10.1155/2019/7145182. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 31583220 Free PMC article.
Risk factors of adverse events in endoscopic retrograde cholangiopancreatography for patients aged ≥85 years.
Takahashi K, Tsuyuguchi T, Sugiyama H, Kumagai J, Nakamura M, Iino Y, Shingyoji A, Yamato M, Ohyama H, Kusakabe Y, Yasui S, Mikata R, Kato N. Takahashi K, et al. Among authors: Kato N. Geriatr Gerontol Int. 2018 Jul;18(7):1038-1045. doi: 10.1111/ggi.13302. Epub 2018 Mar 24. Geriatr Gerontol Int. 2018. PMID: 29573316
3,247 results
Jump to page
Feedback